Article

Geisinger Launches Program to Aid Recovering Pregnant Mothers

Hoping to mitigate the impact of opioid use during pregnancy, Geisinger's Steele Institute for Health Innovation is launching Free2BMom, a new care delivery program to help mothers and their newborns through recovery with social support and other services.

Hoping to mitigate the impact of opioid use during pregnancy, Geisinger's Steele Institute for Health Innovation is launching Free2BMom, a new care delivery program to help mothers and their newborns through recovery with social support and other services. The program will enroll 50 expectant mothers in Luzerne County first its first year, with a care team consisting of a peer recovery specialist, obstetrician/gynecologist, pediatrician, social worker, addiction medicine specialist, and behavior health specialist.

Through the program, Geisinger will collaborate with community organizations to help patients with health and social needs, including transportation, job training, legal service, nutrition, and exercise. It will be available to all pregnant women or those who have recently given birth and are enrolled in medication-assisted treatment, regardless of their ability to pay. Read more about the program.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Merrill H. Stewart, MD
Dr Margrit Wiesendanger
David Awad, PharmD, BCOP
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Dr Margrit Wiesendanger
Nini Wu, MD, Navista
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo